![PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/ae/85/a4/ae85a473-ed8f-49c9-b109-e88019bd4bf8/mza_466067069700462642.jpg/100x100bb.jpg)
George L. Bakris, MD - Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
English - June 25, 2021 23:00 - 1 hour - ★★★★ - 8 ratingsScience cme medical education cme credits peerview insession inreview oncology hematology cne Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Go online to PeerView.com/FNU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live web broadcast, leading experts explore the benefits and limitations of newer potassium binders, such as patiromer and sodium zirconium cyclosilicate, and share evidence-based strategies for managing hyperkalemia to improve patient outcomes. Upon completion of this accredited CE activity, participants should be better able to: Recognize the burden of hyperkalemia in patients with HF and/or CKD, Differentiate current agents for the management of hyperkalemia according to their mechanisms of action, Apply current guidelines and best-available evidence to the management of hyperkalemia in patients with HF and/or CKD, Employ evidence-based strategies for care coordination among the multidisciplinary team members to reduce the risk of readmission for hyperkalemia in patients with HF and/or CKD.